An interventional study of GTR + CGF + bone graft and CGF + bone graft in Concentrated Growth Factors, Periodontal Regeneration and Furcation Defects, sponsored by Jing Qiao. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-06-08.
Sponsored by Jing Qiao · Not applicable, Interventional, and Treatment
Objective: To compare the effect of guided tissue regeneration (GTR) + concentrated growth factors (CGF) + bone graft and CGF + bone graft in the treat of II° furcations of human mandibular molars. Methods: At least thirty II°furcation involvements in mandibular molars will be included and randomly divided into two groups. The experimental group will accept GTR + CGF + bone graft therapy, and the control group will accept CGF + bone graft therapy. The clinical examination and cone beam computed tomography (CBCT) will be performed at baseline and 1 year post-surgery.
Exclusion Criteria:
GTR+CGF+bone graft, CGF
Procedure: GTR + CGF + bone graft
CGF+bone graft
Procedure: CGF + bone graft
Guided tissue regeneration (GTR) combined with CGF and bone graft to treat mandibular furcation involvements
Also known as: CGF Centrifuge machine
CGF combined with bone graft to treat mandibular furcation involvements
Also known as: CGF Centrifuge machine
clinical measurement
Probing depth
Time frame: 1 year
clinical parameter
clinical attachment loss
Time frame: 1 year
radiographic parameter
cone beam computerized tomographic scanning
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.